{"url_path":"/sec/cgtx/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-064863-index.html","accession_number":"0001104659-26-064863","cik":"0001455365","ticker":"CGTX","issuer_name":"COGNITION THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-064863-index.html","primary_entity_key":"0001455365","primary_entity_name":"COGNITION THERAPEUTICS INC"},"word_count":88,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nThe following exhibits\nare being furnished herewith:\n\n \n\n**Exhibit\nNo.**\n \n**Document**\n\n[99.1](tm2615260d1_ex99-1.htm)\n \n[Press Release, dated May 21, 2026.](tm2615260d1_ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**COGNITION THERAPEUTICS, INC.**\n\nDate: May 21, 2026\n \n \n\n \nBy:\n*/s/ Lisa Ricciardi*\n\n \nName:\nLisa Ricciardi\n\n \nTitle:\nPresident and Chief Executive Officer"}